Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery

Leyuan Xu, Remy C. Cooper, Juan Wang, William Andrew Yeudall, Hu Yang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We developed novel dendrimer hydrogels (DHs) on the basis of bioorthogonal chemistry, in which polyamidoamine (PAMAM) dendrimer generation 4.0 (G4) functionalized with strained alkyne, i.e., dibenzocyclooctyne (DBCO), via a PEG spacer (Mn = 2000 g/mol) underwent strain-promoted azide-alkyne cycloaddition (SPAAC) with polyethylene glycol bisazide (PEG-BA) (Mn= 20 000 g/mol) to generate a dendrimer-PEG cross-linked network. This platform offers a high degree of functionality and modularity. A wide range of structural parameters including dendrimer generation, degree of PEGylation, loading density of clickable DBCO groups, PEG-BA chain length, as well as the ratio of clickable dendrimer to PEG-BA, and their concentrations can be readily manipulated to tune the chemical and physical properties of bioorthogonal DHs. We used this platform to prepare an injectable liquid DH. This bioorthogonal DH exhibited high cytocompatibility and enabled the sustained release of the physically loaded anticancer drug 5-fluorouracil (5-FU). Following intratumoral injection, the DH/5-FU formulation significantly suppressed tumor growth and improved the survival of HN12 tumor-bearing mice by promoting tumor cell death as well as by reducing tumor cell proliferation and angiogenesis.

Original languageEnglish (US)
Pages (from-to)1641-1653
Number of pages13
JournalACS Biomaterials Science and Engineering
Volume3
Issue number8
DOIs
StatePublished - Aug 14 2017

Fingerprint

Dendrimers
Hydrogels
Drug delivery
Polyethylene glycols
Tumors
Alkynes
Fluorouracil
Bearings (structural)
Azides
Cycloaddition
Cell proliferation
Cell death
Chain length
Chemical properties
Physical properties

Keywords

  • chemotherapy
  • copper-free click chemistry
  • hydrogel
  • local drug delivery
  • nanomedicine

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering

Cite this

Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery. / Xu, Leyuan; Cooper, Remy C.; Wang, Juan; Yeudall, William Andrew; Yang, Hu.

In: ACS Biomaterials Science and Engineering, Vol. 3, No. 8, 14.08.2017, p. 1641-1653.

Research output: Contribution to journalArticle

@article{2a84dda16ecb4c0987e0a6797b3ea241,
title = "Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery",
abstract = "We developed novel dendrimer hydrogels (DHs) on the basis of bioorthogonal chemistry, in which polyamidoamine (PAMAM) dendrimer generation 4.0 (G4) functionalized with strained alkyne, i.e., dibenzocyclooctyne (DBCO), via a PEG spacer (Mn = 2000 g/mol) underwent strain-promoted azide-alkyne cycloaddition (SPAAC) with polyethylene glycol bisazide (PEG-BA) (Mn= 20 000 g/mol) to generate a dendrimer-PEG cross-linked network. This platform offers a high degree of functionality and modularity. A wide range of structural parameters including dendrimer generation, degree of PEGylation, loading density of clickable DBCO groups, PEG-BA chain length, as well as the ratio of clickable dendrimer to PEG-BA, and their concentrations can be readily manipulated to tune the chemical and physical properties of bioorthogonal DHs. We used this platform to prepare an injectable liquid DH. This bioorthogonal DH exhibited high cytocompatibility and enabled the sustained release of the physically loaded anticancer drug 5-fluorouracil (5-FU). Following intratumoral injection, the DH/5-FU formulation significantly suppressed tumor growth and improved the survival of HN12 tumor-bearing mice by promoting tumor cell death as well as by reducing tumor cell proliferation and angiogenesis.",
keywords = "chemotherapy, copper-free click chemistry, hydrogel, local drug delivery, nanomedicine",
author = "Leyuan Xu and Cooper, {Remy C.} and Juan Wang and Yeudall, {William Andrew} and Hu Yang",
year = "2017",
month = "8",
day = "14",
doi = "10.1021/acsbiomaterials.7b00166",
language = "English (US)",
volume = "3",
pages = "1641--1653",
journal = "ACS Biomaterials Science and Engineering",
issn = "2373-9878",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery

AU - Xu, Leyuan

AU - Cooper, Remy C.

AU - Wang, Juan

AU - Yeudall, William Andrew

AU - Yang, Hu

PY - 2017/8/14

Y1 - 2017/8/14

N2 - We developed novel dendrimer hydrogels (DHs) on the basis of bioorthogonal chemistry, in which polyamidoamine (PAMAM) dendrimer generation 4.0 (G4) functionalized with strained alkyne, i.e., dibenzocyclooctyne (DBCO), via a PEG spacer (Mn = 2000 g/mol) underwent strain-promoted azide-alkyne cycloaddition (SPAAC) with polyethylene glycol bisazide (PEG-BA) (Mn= 20 000 g/mol) to generate a dendrimer-PEG cross-linked network. This platform offers a high degree of functionality and modularity. A wide range of structural parameters including dendrimer generation, degree of PEGylation, loading density of clickable DBCO groups, PEG-BA chain length, as well as the ratio of clickable dendrimer to PEG-BA, and their concentrations can be readily manipulated to tune the chemical and physical properties of bioorthogonal DHs. We used this platform to prepare an injectable liquid DH. This bioorthogonal DH exhibited high cytocompatibility and enabled the sustained release of the physically loaded anticancer drug 5-fluorouracil (5-FU). Following intratumoral injection, the DH/5-FU formulation significantly suppressed tumor growth and improved the survival of HN12 tumor-bearing mice by promoting tumor cell death as well as by reducing tumor cell proliferation and angiogenesis.

AB - We developed novel dendrimer hydrogels (DHs) on the basis of bioorthogonal chemistry, in which polyamidoamine (PAMAM) dendrimer generation 4.0 (G4) functionalized with strained alkyne, i.e., dibenzocyclooctyne (DBCO), via a PEG spacer (Mn = 2000 g/mol) underwent strain-promoted azide-alkyne cycloaddition (SPAAC) with polyethylene glycol bisazide (PEG-BA) (Mn= 20 000 g/mol) to generate a dendrimer-PEG cross-linked network. This platform offers a high degree of functionality and modularity. A wide range of structural parameters including dendrimer generation, degree of PEGylation, loading density of clickable DBCO groups, PEG-BA chain length, as well as the ratio of clickable dendrimer to PEG-BA, and their concentrations can be readily manipulated to tune the chemical and physical properties of bioorthogonal DHs. We used this platform to prepare an injectable liquid DH. This bioorthogonal DH exhibited high cytocompatibility and enabled the sustained release of the physically loaded anticancer drug 5-fluorouracil (5-FU). Following intratumoral injection, the DH/5-FU formulation significantly suppressed tumor growth and improved the survival of HN12 tumor-bearing mice by promoting tumor cell death as well as by reducing tumor cell proliferation and angiogenesis.

KW - chemotherapy

KW - copper-free click chemistry

KW - hydrogel

KW - local drug delivery

KW - nanomedicine

UR - http://www.scopus.com/inward/record.url?scp=85027244722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027244722&partnerID=8YFLogxK

U2 - 10.1021/acsbiomaterials.7b00166

DO - 10.1021/acsbiomaterials.7b00166

M3 - Article

VL - 3

SP - 1641

EP - 1653

JO - ACS Biomaterials Science and Engineering

JF - ACS Biomaterials Science and Engineering

SN - 2373-9878

IS - 8

ER -